» Articles » PMID: 36139626

Unraveling the Structural Variations of Early-Stage Mycosis Fungoides-CD3 Based Purification and Third Generation Sequencing As Novel Tools for the Genomic Landscape in CTCL

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Sep 23
PMID 36139626
Authors
Affiliations
Soon will be listed here.
Abstract

Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL). At present, knowledge of genetic changes in early-stage MF is insufficient. Additionally, low tumor cell fraction renders calling of copy-number variations as the predominant mutations in MF challenging, thereby impeding further investigations. We show that enrichment of T cells from a biopsy of a stage I MF patient greatly increases tumor fraction. This improvement enables accurate calling of recurrent MF copy-number variants such as and deletion and amplification, undetected in the unprocessed biopsy. Furthermore, we demonstrate that application of long-read nanopore sequencing is especially useful for the structural variant rich CTCL. We detect the structural variants underlying recurrent MF copy-number variants and show phasing of multiple breakpoints into complex structural variant haplotypes. Additionally, we record multiple occurrences of templated insertion structural variants in this sample. Taken together, this study suggests a workflow to make the early stages of MF accessible for genetic analysis, and indicates long-read sequencing as a major tool for genetic analysis for MF.

Citing Articles

T-Cell Receptor Rearrangements in Early Stages of Mycosis Fungoides May Be Associated with Pronounced Copy Number Variations: A Prognostic Factor?.

Hain C, Cieslak C, Kalinowski J, Stadler R Cancers (Basel). 2025; 17(3).

PMID: 39941921 PMC: 11817690. DOI: 10.3390/cancers17030556.


Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma.

Cieslak C, Hain C, Ruckert-Reed C, Busche T, Klages L, Schaper-Gerhardt K Cancers (Basel). 2024; 16(21).

PMID: 39518138 PMC: 11544856. DOI: 10.3390/cancers16213700.


Advances in the understanding and treatment of Cutaneous T-cell Lymphoma.

Bakr F, Whittaker S Front Oncol. 2022; 12:1043254.

PMID: 36505788 PMC: 9729763. DOI: 10.3389/fonc.2022.1043254.

References
1.
Hristov A, Tejasvi T, Wilcox R . Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019; 94(9):1027-1041. DOI: 10.1002/ajh.25577. View

2.
Frith M, Mitsuhashi S, Katoh K . lamassemble: Multiple Alignment and Consensus Sequence of Long Reads. Methods Mol Biol. 2020; 2231:135-145. DOI: 10.1007/978-1-0716-1036-7_9. View

3.
Tirumalae R, Panjwani P . Origin Use of CD4, CD8, and CD1a Immunostains in Distinguishing Mycosis Fungoides from its Inflammatory Mimics: A Pilot Study. Indian J Dermatol. 2012; 57(6):424-7. PMC: 3519247. DOI: 10.4103/0019-5154.103060. View

4.
Roberts H, Lopopolo M, Pagnamenta A, Sharma E, Parkes D, Lonie L . Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma. Sci Rep. 2021; 11(1):6408. PMC: 7979876. DOI: 10.1038/s41598-021-85354-8. View

5.
Marshall A, Roes M, Passos D, DeWeerd M, Chaikovsky A, Sage J . Deletion in Retinoblastoma Protein Pathway-Disrupted Cells Results in DNA Damage and Cancer Progression. Mol Cell Biol. 2019; 39(16). PMC: 6664603. DOI: 10.1128/MCB.00105-19. View